As of April 16, 2025, Corbus Pharmaceuticals (CRBP) has a market cap of $73.271 million USD. According to our data, Corbus Pharmaceuticals is ranked No.7814 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $73.27 M |
-49.02%
|
Dec 31, 2024 | $0.14 B |
95.36%
|
Dec 29, 2023 | $73.56 M |
81.38%
|
Dec 30, 2022 | $40.56 M |
-81.98%
|
Dec 31, 2021 | $0.23 B |
-50.72%
|
Dec 31, 2020 | $0.46 B |
-77.11%
|
Dec 31, 2019 | $2.00 B |
-6.51%
|
Dec 31, 2018 | $2.13 B |
-17.75%
|
Dec 29, 2017 | $2.59 B |
-15.98%
|
Dec 30, 2016 | $3.09 B |
412.12%
|
Dec 31, 2015 | $0.60 B |
-44.82%
|
Dec 31, 2014 | $1.09 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() FibroGen
FGEN
|
$29.89 M |
0.000 M
|
![]() USA
|
![]() Galapagos NV
GLPG
|
$1.57 B |
-0.000 M
|
![]() Belgium
|
![]() Cytokinetics
CYTK
|
$4.60 B |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
Market Cap | = | CRBP Stock Price | * | CRBP Shares Outstanding |
= | $5.99 | * | 12.23 M | |
= | $73.27 M |